Home>Clinical research>Clinical trials by disease>Oral QLT091001 in Retinitis Pigmentosa (RP) Subjects With an Autosomal Dominant Mutation in Retinal Pigment Epithelial 65 Protein (RPE65)

How to use the speech recognition tool?

RET RP 01 - NCT01543906

Oral QLT091001 in Retinitis Pigmentosa (RP) Subjects With an Autosomal Dominant Mutation in Retinal Pigment Epithelial 65 Protein (RPE65)

Oral QLT091001 in Retinitis Pigmentosa (RP) Subjects With an Autosomal Dominant
Mutation in Retinal Pigment Epithelial 65 Protein (RPE65).

Type: Interventional



Status of the trial: Completed

Orphan Drug Recognition: No

Inclusion

  • Opening Date: 2012-02-01
  • Closing Date: 2014-07-01

Criteria

More information

Children: No

Adults: Yes

Funder Type: industry

HCP: Principal investigators

HCP: Other investigators

Within ERN-EYE members

Principal investigators



Other investigators

Workgroups

  • Retinal Rare Eye Diseases (WG1)

Subscribe

* indicates required

This ERN is supported by: